Skip to main content

Grafa News and Videos — Page 1410

Latest

Grafa

RedHill Biopharma reports FY results, highlights strategic licensing and legal victories

RedHill Biopharma (NASDAQ:RDHL) reported its full-year 2025 financial results and operational highlights on Monday, April 27, 2026, marking a year of significant portfolio high-grading and successful litigation.

Read more: RedHill Biopharma reports FY results, highlights strategic licensing and legal victories

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift